What role will genetics play in a biology-based approach to psychiatry?

| May 10, 2013
f b bfd z e
Credit: Flickr/Life Mental Health.
This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

The following is an editorial summary.

In anticipation of the publication of the DSM-V — the fifth edition of psychiatry’s “Bible” — many, many articles have been written calling out the manual’s apparent refusal to adopt a more biologically-based approach to mental illness. Even in a world of increasingly sophisticated neuroscience, biochemistry, and genetics, the authors of the manual climb to a nebulous, symptom-focused approach to diagnosing and treating mental illness.

While several articles, including this New York Times piece, offer a thorough breakdown of the larger controversy, very few are focusing on what, exactly a biology-based psychiatry would look like. Genetics is almost universally invoked as one of the disciplines that should play a key role, but just how prepared genetics is to tackle the issue of mental illness is an open question. The folks at the DNA Exchange deserve special mention for examining how a biology-based psychiatry with a strong element of genetics would impact the work of genetic counselors and the field of psychiatry more generally.

Additional Resources:

The GLP featured this article to reflect the diversity of news, opinion and analysis. The viewpoint is the author’s own. The GLP’s goal is to stimulate constructive discourse on challenging science issues.

Share via
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.
Send this to a friend